Gerbsman Partners, a crisis management and private investment banking firm, announces a strategic alliance with Foundation Ventures, a New York City based life science boutique investment bank focused on biotechnology, medical device, and healthcare services companies seeking to raise institutional venture capital or growth capital. Foundation Ventures also provides M&A, strategic partnering and fairness opinion advisory services. Through its affiliate, Prelude Ventures, Foundation Ventures also invests in biotechnology and medical device companies; including bridge financing and syndicate participation opportunities.
Steven R. Gerbsman, Managing Principal of Gerbsman Partners, “This strategic alliance with Foundation Ventures will provide Gerbsman Partners life science and medical device clients with access to early stage and expansion capital. It will also provide the capability for Foundation Ventures to assist potential clients that are in the restructuring and/or distressed stages.”
Philip Taub, Managing Partner of Foundation Ventures, “We see the restructuring and distressed company market as an additional business opportunity in 2011. With our current focus on early stage and expansion capital funding for life science, medical device, and healthcare services companies, this alliance will allow us to concentrate on our core business, while providing us access to the expertise of Gerbsman Partners in maximizing value for companies that are restructuring or distressed.”
About Gerbsman Partners
Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. Since 2001, Gerbsman Partners has been involved in maximizing value for 68 technology, life science and medical device companies and their Intellectual Property and has restructured/terminated over $795 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A Transactions.
Gerbsman Partners has offices and strategic alliances in San Francisco, Boston, New York, Washington, DC, Alexandria, VA, Europe and Israel.